Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human umbilical cord-derived mesenchymal stem cells for complex perianal fistulas in Crohn's disease (Phase I/II)
CTR20260493Phase 2Active
- Sponsor
- Beike Biotechnology
- Start
- Feb 2026
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord derived mesenchymal stem cells in Crohn's disease, sponsored by Beike Biotechnology. Started Feb 2026; status: active.
02
Drugs
human umbilical cord derived mesenchymal stem cells
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on CTR20260493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260493.